Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe Haemophilia”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02727647
What this trial is testing

Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients

Who this might be right for
Hemophilia A
Chulalongkorn University 16
Not applicableStudy completedNCT01053715
What this trial is testing

Quality of Life Study of Helixate NexGen

Who this might be right for
Hemophilia A
CSL Behring 78
Large-scale testing (Phase 3)UnknownNCT02930317
What this trial is testing

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT06003387
What this trial is testing

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

Who this might be right for
Hemophilia B
CSL Behring 35
Post-approval studies (Phase 4)Study completedNCT03449342
What this trial is testing

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 60
Post-approval studies (Phase 4)Study completedNCT00243386
What this trial is testing

Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Not applicableUnknownNCT05218772
What this trial is testing

Objective and Perceived Health Status of Elderly People With Moderate or Severe Haemophilia in France: an Ancillary Study of the FranceCoag Registry

Who this might be right for
Moderate or Serious Haemophilia
Assistance Publique Hopitaux De Marseille 612
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05987449
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 60
Not applicableStudy completedNCT02971969
What this trial is testing

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Large-scale testing (Phase 3)Active Not RecruitingNCT03861273
What this trial is testing

Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 51
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Early research (Phase 1)Study completedNCT01579903
What this trial is testing

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

Who this might be right for
Hemophilia A
Pfizer 16
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Not applicableStudy completedNCT05360706
What this trial is testing

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Who this might be right for
Hemophilia B
CSL Behring 9
Post-approval studies (Phase 4)UnknownNCT02479087
What this trial is testing

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

Who this might be right for
Hemophilia A
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation